B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CFL1

MOLECULAR TARGET

cofilin 1

UniProt: P23528NCBI Gene: 10726 compounds

CFL1 (cofilin 1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CFL1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sertraline1.102
2Cinnarizine0.691
3Clofibrate0.691
4Clotrimazole0.691
5Fenofibrate0.691
6Rotenone0.691

About CFL1 as a Drug Target

CFL1 (cofilin 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented CFL1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CFL1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.